Caligan Partners’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $136M | Hold |
1,436,878
| – | – | 26.13% | 1 |
|
|
2025
Q1 | $91.2M | Hold |
1,436,878
| – | – | 19.04% | 2 |
|
|
2024
Q4 | $66.7M | Hold |
1,436,878
| – | – | 16.9% | 2 |
|
|
2024
Q3 | $41.3M | Sell |
1,436,878
-406,878
| -22% | -$11.7M | 13.1% | 2 |
|
|
2024
Q2 | $26.7M | Buy |
1,843,756
+547,309
| +42% | +$7.91M | 6.23% | 6 |
|
|
2024
Q1 | $20.9M | Buy |
1,296,447
+1,113,383
| +608% | +$17.9M | 5.51% | 6 |
|
|
2023
Q4 | $3.64M | Hold |
183,064
| – | – | 1.23% | 9 |
|
|
2023
Q3 | $2.98M | Hold |
183,064
| – | – | 1.37% | 7 |
|
|
2023
Q2 | $3.87M | Hold |
183,064
| – | – | 2.18% | 7 |
|
|
2023
Q1 | $3.68M | Hold |
183,064
| – | – | 2.56% | 7 |
|
|
2022
Q4 | $4.78M | Buy |
+183,064
| New | +$4.78M | 3.98% | 6 |
|